Discovery of novel drug combinations for clinical development
Ended Awarded Last action
- Contract number
- HHSN26100032
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,741,760
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $2,741,760.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $41,192 | |
| Other Administrative Action | $0 | |
| Original award | $2,700,568 |
About this award
This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The $2,741,760.00 contract is for the discovery of novel drug combinations for clinical development. The award is a Delivery Order under a larger Indefinite Delivery Contract with a potential value of $6.6 billion over 5 years, establishing Leidos Biomedical Research Inc. as a Federally Funded Research and Development Center (FFRDC) contractor for NCI. The work is primarily performed at Leidos Biomedical Research facilities in Maryland. This contract does not have a set-aside designation. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and provides a broad range of research, development, and production services, with a focus on supporting biomedical research programs at NIH.
Quick answers
Who was awarded contract HHSN26100032?
HHSN26100032 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2016.
How much is contract HHSN26100032 worth?
The government has obligated $2,741,760 on HHSN26100032.
Is contract HHSN26100032 an order under another contract?
Yes. HHSN26100032 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100032 competed?
The extent of competition for HHSN26100032 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award